Report Detail
Global Drugs for Malaria Market Insights, Forecast to 2025
- RnM2945995 |
- 09 March, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
The global Drugs for Malaria market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs for Malaria market based on company, product type, end user and key regions.
This report studies the global market size of Drugs for Malaria in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Malaria in these regions.
This research report categorizes the global Drugs for Malaria market by top players/brands, region, type and end user. This report also studies the global Drugs for Malaria market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Market size by Product
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Market size by End User
Prevention
Treatment
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Drugs for Malaria market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drugs for Malaria market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Malaria companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drugs for Malaria submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Drugs for Malaria are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Malaria market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Drugs for Malaria Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Drugs for Malaria Market Size Growth Rate by Product
- 1.4.2 Aryl Aminoalcohol Compounds
- 1.4.3 Antifolate Compounds
- 1.4.4 Artemisinin Compounds
- 1.5 Market by End User
- 1.5.1 Global Drugs for Malaria Market Size Growth Rate by End User
- 1.5.2 Prevention
- 1.5.3 Treatment
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Drugs for Malaria Market Size
- 2.1.1 Global Drugs for Malaria Revenue 2014-2025
- 2.1.2 Global Drugs for Malaria Sales 2014-2025
- 2.2 Drugs for Malaria Growth Rate by Regions
- 2.2.1 Global Drugs for Malaria Sales by Regions
- 2.2.2 Global Drugs for Malaria Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Drugs for Malaria Sales by Manufacturers
- 3.1.1 Drugs for Malaria Sales by Manufacturers
- 3.1.2 Drugs for Malaria Sales Market Share by Manufacturers
- 3.1.3 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)
- 3.2 Drugs for Malaria Revenue by Manufacturers
- 3.2.1 Drugs for Malaria Revenue by Manufacturers (2014-2019)
- 3.2.2 Drugs for Malaria Revenue Share by Manufacturers (2014-2019)
- 3.3 Drugs for Malaria Price by Manufacturers
- 3.4 Drugs for Malaria Manufacturing Base Distribution, Product Types
- 3.4.1 Drugs for Malaria Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Drugs for Malaria Product Type
- 3.4.3 Date of International Manufacturers Enter into Drugs for Malaria Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Drugs for Malaria Sales by Product
- 4.2 Global Drugs for Malaria Revenue by Product
- 4.3 Drugs for Malaria Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Drugs for Malaria Breakdown Data by End User
6 North America
- 6.1 North America Drugs for Malaria by Countries
- 6.1.1 North America Drugs for Malaria Sales by Countries
- 6.1.2 North America Drugs for Malaria Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Drugs for Malaria by Product
- 6.3 North America Drugs for Malaria by End User
7 Europe
- 7.1 Europe Drugs for Malaria by Countries
- 7.1.1 Europe Drugs for Malaria Sales by Countries
- 7.1.2 Europe Drugs for Malaria Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Drugs for Malaria by Product
- 7.3 Europe Drugs for Malaria by End User
8 Asia Pacific
- 8.1 Asia Pacific Drugs for Malaria by Countries
- 8.1.1 Asia Pacific Drugs for Malaria Sales by Countries
- 8.1.2 Asia Pacific Drugs for Malaria Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Drugs for Malaria by Product
- 8.3 Asia Pacific Drugs for Malaria by End User
9 Central & South America
- 9.1 Central & South America Drugs for Malaria by Countries
- 9.1.1 Central & South America Drugs for Malaria Sales by Countries
- 9.1.2 Central & South America Drugs for Malaria Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Drugs for Malaria by Product
- 9.3 Central & South America Drugs for Malaria by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Drugs for Malaria by Countries
- 10.1.1 Middle East and Africa Drugs for Malaria Sales by Countries
- 10.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Drugs for Malaria by Product
- 10.3 Middle East and Africa Drugs for Malaria by End User
11 Company Profiles
- 11.1 Cipla
- 11.1.1 Cipla Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Cipla Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Cipla Drugs for Malaria Products Offered
- 11.1.5 Cipla Recent Development
- 11.2 Guilin Pharmaceutical
- 11.2.1 Guilin Pharmaceutical Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Guilin Pharmaceutical Drugs for Malaria Products Offered
- 11.2.5 Guilin Pharmaceutical Recent Development
- 11.3 IPCA Laboratories
- 11.3.1 IPCA Laboratories Company Details
- 11.3.2 Company Business Overview
- 11.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 IPCA Laboratories Drugs for Malaria Products Offered
- 11.3.5 IPCA Laboratories Recent Development
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Company Details
- 11.4.2 Company Business Overview
- 11.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 GlaxoSmithKline Drugs for Malaria Products Offered
- 11.4.5 GlaxoSmithKline Recent Development
- 11.5 Mylan Labs
- 11.5.1 Mylan Labs Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Mylan Labs Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Mylan Labs Drugs for Malaria Products Offered
- 11.5.5 Mylan Labs Recent Development
- 11.6 Roche
- 11.6.1 Roche Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Roche Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Roche Drugs for Malaria Products Offered
- 11.6.5 Roche Recent Development
- 11.7 Novartis
- 11.7.1 Novartis Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Novartis Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Novartis Drugs for Malaria Products Offered
- 11.7.5 Novartis Recent Development
- 11.8 Sanofi Aventis
- 11.8.1 Sanofi Aventis Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sanofi Aventis Drugs for Malaria Products Offered
- 11.8.5 Sanofi Aventis Recent Development
- 11.9 Ajanta Pharma
- 11.9.1 Ajanta Pharma Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Ajanta Pharma Drugs for Malaria Products Offered
- 11.9.5 Ajanta Pharma Recent Development
12 Future Forecast
- 12.1 Drugs for Malaria Market Forecast by Regions
- 12.1.1 Global Drugs for Malaria Sales Forecast by Regions 2019-2025
- 12.1.2 Global Drugs for Malaria Revenue Forecast by Regions 2019-2025
- 12.2 Drugs for Malaria Market Forecast by Product
- 12.2.1 Global Drugs for Malaria Sales Forecast by Product 2019-2025
- 12.2.2 Global Drugs for Malaria Revenue Forecast by Product 2019-2025
- 12.3 Drugs for Malaria Market Forecast by End User
- 12.4 North America Drugs for Malaria Forecast
- 12.5 Europe Drugs for Malaria Forecast
- 12.6 Asia Pacific Drugs for Malaria Forecast
- 12.7 Central & South America Drugs for Malaria Forecast
- 12.8 Middle East and Africa Drugs for Malaria Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Drugs for Malaria Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Drugs for Malaria . Industry analysis & Market Report on Drugs for Malaria is a syndicated market report, published as Global Drugs for Malaria Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drugs for Malaria market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
